checkAd
    Startseite > Aktien > TFF Pharmaceuticals > Nachrichten
    TFF Pharmaceuticals Aktie
    1,7800
     
    USD
    -2,20 %
    -0,0400 USD
    Letzter Kurs 08.06.24 Nasdaq
    1,7500
     
    USD
    2.700 STK
    Geldkurs 07.06.24
    1,8100
     
    USD
    600 STK
    Briefkurs 07.06.24
    ISIN: US87241J2033 · WKN: A3E2FW · SYM: TFFP · USA

    Neueste Nachrichten

    TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TAC
    19.12.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC
    18.12.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals Announces Reverse Stock Split
    15.12.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors
    30.11.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
    30.11.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference – December 7, 2023
    27.11.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
    14.11.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023
    07.11.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccines
    02.10.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals to Participate in Upcoming Investor Conferences
    28.09.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023
    23.08.23 · globenewswire · TFF Pharmaceuticals
    TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
    17.08.23 · globenewswire · TFF Pharmaceuticals